Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2024-10-31
- Target Recruit Count
- 80
- Registration Number
- NCT06667973
HRQoL and Financial Toxicity in Patients with VEXAS Syndrome
Not yet recruiting
- Conditions
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2024-10-26
- Target Recruit Count
- 100
- Registration Number
- NCT06657846
- Locations
- 🇮🇹
Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
🇮🇹Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia, Bergamo, Italy
🇮🇹Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy
Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)
Not yet recruiting
- Conditions
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-07-22
- Target Recruit Count
- 397
- Registration Number
- NCT06513273
Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010
Not yet recruiting
- Conditions
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-06-20
- Target Recruit Count
- 157
- Registration Number
- NCT06466824
PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-10
- Last Posted Date
- 2024-06-18
- Target Recruit Count
- 160
- Registration Number
- NCT06409936
Biological and Clinical Efficacy of Shingrix in Patients With CLL
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-04-15
- Last Posted Date
- 2024-05-09
- Target Recruit Count
- 312
- Registration Number
- NCT06364033
- Locations
- 🇮🇹
UOC Ematologia ASST dei Sette Laghi, Varese, Italy
Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2024-11-08
- Target Recruit Count
- 31
- Registration Number
- NCT06253637
- Locations
- 🇮🇹
Ematologia AOU Careggi, Firenze, Italy
🇮🇹Ematologia P.O. Vito Fazzi - Lecce, Lecce, Italy
🇮🇹Ematologia AOU Policlinico Umberto I, Roma, Italy
Real-world Ruxolitinib Experience in PV
Not yet recruiting
- Conditions
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-05-09
- Target Recruit Count
- 153
- Registration Number
- NCT06251102
Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-04-10
- Target Recruit Count
- 225
- Registration Number
- NCT06090786
Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2024-04-10
- Target Recruit Count
- 73
- Registration Number
- NCT06084923
© Copyright 2024. All Rights Reserved by MedPath